MAPK15 and cancer: In the present study, we revealed that MAPK15 is more highly expressed in the tissues of LUAD patients with lymph node metastasis (Figure 1B), and MAPK15 interacts with p50 to promote EP3 expression at the transcriptional level (Figure 6), thereby enhancing cancer cell migration and metastasis.